TOP NEWS
The World Can No Longer Sideline the Israeli-Palestinian Issue. But the U.S. Doesn’t Have to Be the Only Broker.
For years, the U.S. pushed the issue to the sidelines in foreign policy. Insiders say it needs to take center stage again, and there might be a better way to do it this time.
Glenn Youngkin wants Republicans to talk about abortion. Really.
If it works, it could become a blueprint for the GOP and further elevate Youngkin’s profile.
California Playbook
Inside the Golden State political arena


California Playbook
Inside the Golden State political arena
By signing up, you acknowledge and agree to our Privacy Policy and Terms of Use. You may unsubscribe at any time by following the directions at the bottom of the newsletter or by contacting us here. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
To end Hamas, Israel may need to grieve first
Israelis say they want to eliminate the group that terrorized them, but the challenge is how to avoid causing new problems.
Menendez accused of acting as foreign agent for Egypt while helming Senate Foreign Relations Committee
Federal prosecutors added the new criminal charge against the New Jersey Democrat and his wife.
DeSantis’ slide left an opening in N.H. Now it’s anyone’s race for second place.
Donald Trump will return to New Hampshire this month, after rivals descend on the state this weekend.
How prosecutors expanded their case against George Santos
The New York Republican faces a growing slate of charges as federal prosecutors seek to dismantle what they’ve called a campaign operation rife with fraud.
White House calls top lawmakers over to discuss Israel aid package
Lawmakers to include top House appropriators and members of Foreign Affairs panel.
Why Katie Porter sounds like a Republican on Iran and Hamas
One of the three leading Democrats vying for the late Sen. Dianne Feinstein’s seat, Porter recently suggested the surprise attack on Israel by Gaza militants was, in part, a result of American inaction in Iran.
What’s in a name? Why unmet medical needs are riling the pharma industry.
The EU wants to steer drug development to cover research gaps, but industry hates the idea.
MOST READ
Have a news tip?
Contact POLITICO reporters and provide materials in an anonymous and secure way. Learn more »
Exclusive news, intelligence and tools for professionals on the front lines of policy. Learn more »




















































